PM Group
Mark McMackin is a seasoned professional in the biotechnology and pharmaceutical sectors, currently serving as a Senior Principal Technical Representative at Eli Lilly and Company since July 2023, focusing on Clinical Trial Drug Product Supply. Previously held roles include CQV Engineer at both Merck Group and Lilly Limerick, as well as positions at MeiraGTx, Pfizer, and Regeneron Pharmaceuticals in various capacities related to tech transfer, validation, and biotech production. Mark's educational background includes a Bachelor's Degree in Biotechnology from the University of Galway and ongoing postgraduate studies in Digital Transformation at Griffith College Dublin.
This person is not in any teams
PM Group
4 followers
PM Group is an employee owned, international project delivery firm with a network of offices in Europe, Asia and the USA. Our team of 3,500+ people manage the design, construction and commissioning of high-tech facilities. Over 50 years, we’ve built our expertise working for the world's leading pharma, food, data centre and medical technology companies. We have an excellent track record in the advanced manufacturing and energy sectors. To excel at the complex work we do, we always seek to understand our clients' needs. At every level of our business you will see a culture of honesty, openness and flexibility. Our approach has led to long-term, trusted relationships with our clients. Learn more about PM Group : www.pmgroup-global.com In 2023, we were delighted to welcome Milestone to PM Group. Milestone is a dynamic automation and digital systems consultancy. The Company provides world-leading services to the Life Sciences and FMCG sectors. With 160+ experts, Milestone has extensive experience covering lean analysis, process optimisation, system integration, equipment automation, MES solutions, manufacturing intelligence and project management. To find out more about Milestone, visit : www.mile.ie (disclaimer and legal information can be found at: www.pmgroup-global.com)